FII, DII data- FPIs purchased shares worth Rs 2073 Cr, DIIs added shares worth Rs 4794 Cr on December 4, Monday
时间:2024-06-17 17:41:43 阅读(143)
Foreign institutional investors (FII) purchased shares worth net Rs 2,073.21 crore, while domestic institutional investors (DII) added shares worth net Rs 4,797.15 crore on December 4, 2023, according to the provisional data available on the NSE.
For the month till December 4, 2023, FIIs sold shares worth net Rs 4,604.84 crore while DIIs bought shares worth net Rs 5,936.27 crore. In the month of November, FIIs added shares worth net Rs 5,795.05 crore while DIIs added equities worth net Rs 12,762.14 crore.
Previously, on Monday, the NSE Nifty 50 soared 418.90 points or 2.07% to settle at a record high of 20,686.80, while the BSE Sensex jumped 1383.93 points or 2.05% to 68,863.93.
Foreign institutional investors (FII) or Foreign portfolio investors (FPI) are those who invest in the financial assets of a country while not being part of it. On the other hand, domestic institutional investors (DII), as the name suggests, invest in the country they’re living in. Political and economic trends impact the investment decisions of both FIIs and DIIs. Additionally, both types of investors – foreign institutional investors (FIIs) and domestic institutional investors (DIIs) – can impact the economy’s net investment flows.
上一篇:Investors become poorer by Rs 5
下一篇:Xiaomi 12 Pro first look at design, specs, top features and more - In Photos
猜你喜欢
- Ram Temple inauguration- Mamata slams PM Modi’s ‘gimmick show’, says Trinamool against dividing people on religious lines
- IPO flood coming in FY24, after drought of public issues in Q4FY23; here are the upcoming IPOs this year
- IT stocks fall as Epam lowers guidance
- Rating- Buy; Positive outlook for Piramal Pharma’s growth
- Is there a fuel price cut on cards- Petrol, diesel prices may be slashed by upto Rs 6
- Proximity of global AI regulation- Assessing AI safety measures
- Quantum of gold smuggling went up as post Covid related lockdowns eased- DRI report
- Q3FY24 Results Preview- Strong numbers likely from Aurobindo Pharma & Gland Pharma; US sales to improve QoQ for all relevant companies
- Properties registration in Mumbai up 11% at 8,628 units in Sep- Report